Purple Biotech Ltd.
NASDAQ:PPBT
3.82 (USD) • At close December 24, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Purple Biotech Ltd. |
Symbool | PPBT |
Munteenheid | USD |
Prijs | 3.82 |
Beurswaarde | 9,866,105 |
Dividendpercentage | 0% |
52-weken bereik | 2 - 20.6 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Mr. Isaac Israel |
Website | https://purple-biotech.com |
An error occurred while fetching data.
Over Purple Biotech Ltd.
Purple Biotech Ltd., a clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug for cancer patients in the United States. Its oncology pipeline includes CM24, a monoclonal antibody that blocks carcinoembryonic antigen related cell adhesion molecule 1 as a combination therapy with anti-PD-1 checkpoint inhibitors, which
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)